Fundz

Watching Genprex, Inc.? See every signal: funding, hires, M&A, contracts, sentiment.

Book a demoChoose your plan
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →
Back to SEC Filings
Control ChangeItem 5.01 · 8-KHIGH RiskMixed

Genprex, Inc.

Filed: Jul 29, 2026CIK: 0001595248
View on SEC.gov

AI Executive Summary

AI-powered analysis of 8-K filing content

Genprex received a Nasdaq Hearings Panel exception to continue listing on The Nasdaq Capital Market despite not meeting the $1.00 minimum bid price requirement, with until December 7, 2026 to regain compliance. This allows the company to remain publicly traded while addressing its stock price challenges.

Key Takeaways

Nasdaq granted a compliance exception allowing Genprex to remain listed despite failing the $1.00 minimum bid price requirement

Company has until December 7, 2026 to demonstrate compliance with listing standards

2 more takeaways

Related Filings (2)

2 more filings from Genprex, Inc. in the last 90 days

Filing Overview

Form Type8-K
Filing DateJul 29, 2026
Item5.01
CategoryControl Change
CIK0001595248
Accession #gnpx20260730_8k.htm
Risk LevelHIGH
SentimentMixed
Signalrisk
Topics
regulatory

What This Means

Control of the company has changed. This could be through acquisition, proxy contest, or board restructuring.
View Full Filing on SEC.govBrowse More Filings

Genprex, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.